Capitainer to raise SEK 15M from Nordic Consumer Health and the US-based Wolf Family

Sweden Investments 11 March 2020
Share on FacebookShare on Twitter

Capitainer, a Stockholm, Sweden-based company developing a technology that offers a solution for near-patient blood sampling, announced raising SEK 15M ($1.6M) in capital investment.

The funding was led by Nordic Consumer Health and the US-based Wolf Family Trust, and included financial participation from a group of Nordic angel investors.

The proceeds will be used to support the commercialization of its dried-blood-spot sampling product, Capitainer qDBS.

Capitainer, founded in 2016 and led by CEO Christopher Aulin, developed a device called Capitainer qDBS used for easy-to-use home blood sampling.

Capitainer qDBS is being developed to ensure that an exact sample volume of 10µl of blood is collected and to enable convenient and quantitative blood sampling at the fingertip.

Patients place a blood drop on a card that automatically fills a microchannel with the required amount of blood and discards any excess, eliminating the potential for human error. The blood volume contained in the microchannel automatically flows to pre-punched dried-blood-spot paper, forming an accurate and high-quality dried-blood-spot sample preserved for quantitative analysis, the company said. The filled card can then be safely transported to the laboratory for analysis without the need for refrigeration or specialized packaging.